ImmuCell Corporation (ICCC) News
Track canonical SquawkNews coverage tagged to ICCC, ImmuCell Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ImmuCell reports Q2 2026 results, expands capacity plans
ImmuCell reported second-quarter product sales of $7.2 million, net income of $1.8 million and gross margin of 33.9%, while planning $8 million in capacity investments.
EARNINGS | Aug 14, 2026, 03:51 PM UTC
L
ImmuCell reports unaudited quarterly financial results
ImmuCell announces unaudited financial results for the quarter ended June 30, 2026.
EARNINGS | Aug 13, 2026, 08:09 PM UTC
L
Immucell reports preliminary Q2 revenue $7.2M
"Total sales for the three months ended June 30, 2026 were $7.2 million, an 11.5% increase compared to the three months ended June 30, 2025, driven by a 27.7% increase in domestic sales compared to 2025," said Timothy Fi
EARNINGS | Jul 09, 2026, 08:12 PM UTC
L
ICCC: CEO Buys 8,000 Shares
IMMUCELL CORP CEO te Boekhorst Paul Francis Olivier P buys 8,000 shares at $9.495
EARNINGS | Jun 22, 2026, 12:34 PM UTC